Jae-Ryong Kim Selected Research

SB 203580

1/2009	Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
7/2008	Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
2/2006	Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
2/2004	Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4.
1/2003	Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Ryong Kim Research Topics

Disease

26	Neoplasms (Cancer) 06/2022 - 01/2003
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2006
12	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2003
11	Inflammation (Inflammations) 01/2021 - 02/2007
9	Atherosclerosis 01/2021 - 12/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2015
5	Hepatocellular Carcinoma (Hepatoma) 05/2010 - 11/2002
4	Hypertension (High Blood Pressure) 01/2021 - 02/2018
3	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 02/2004
3	Dementia (Dementias) 01/2021 - 10/2019
3	Body Weight (Weight, Body) 01/2019 - 04/2007
3	Hyperlipidemias (Hyperlipidemia) 03/2018 - 06/2010
3	Rheumatoid Arthritis 01/2016 - 08/2004
3	Alzheimer Disease (Alzheimer's Disease) 05/2008 - 10/2003
2	Infections 02/2021 - 12/2010
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2017
2	Amyloid Plaque 01/2021 - 10/2003
2	Necrosis 01/2021 - 10/2016
2	Fibrosis (Cirrhosis) 02/2020 - 01/2018
2	Prehypertension 01/2019 - 01/2018
2	Insulin Resistance 01/2019 - 06/2014
2	Fatty Liver 03/2018 - 07/2017
2	Hyperglycemia 07/2017 - 02/2010
2	Metabolic Diseases (Metabolic Disease) 08/2016 - 02/2010
2	Hearing Loss (Hearing Impairment) 04/2016 - 12/2015
2	Atrial Fibrillation 07/2014 - 06/2011
2	Angina Pectoris 04/2012 - 02/2009
2	Auditory neuropathy 08/2011 - 10/2007
2	Diabetes Mellitus 02/2010 - 02/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010 - 01/2010
2	Obesity 01/2010 - 09/2009
2	Cognitive Dysfunction 05/2008 - 06/2007
2	Neuroblastoma 01/2008 - 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	COVID-19 02/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Fibrosarcoma 10/2019

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
14	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2019 - 01/2003
11	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2008
10	HDL LipoproteinsIBA 02/2021 - 01/2008
10	LipidsIBA 01/2019 - 02/2010
9	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2014 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 01/2016 - 06/2007
7	Plasminogen Activators (Plasminogen Activator)IBA 05/2014 - 02/2006
6	Complementary DNA (cDNA)IBA 01/2013 - 01/2008
5	AntioxidantsIBA 02/2021 - 02/2010
5	CholesterolIBA 01/2021 - 01/2008
5	HDL CholesterolIBA 01/2021 - 01/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 06/2009
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2011 - 04/2007
5	Phosphotransferases (Kinase)IBA 06/2009 - 02/2004
5	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2009 - 01/2003
5	SB 203580IBA 01/2009 - 01/2003
4	oxidized low density lipoproteinIBA 01/2021 - 02/2010
4	ApolipoproteinsIBA 01/2021 - 01/2008
4	policosanolIBA 01/2019 - 01/2018
4	Cholesterol Ester Transfer ProteinsIBA 03/2018 - 01/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2008 - 01/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2009
3	Triglycerides (Triacylglycerol)IBA 07/2014 - 01/2008
3	p38 Mitogen-Activated Protein KinasesIBA 01/2009 - 01/2003
3	PlasminogenIBA 07/2008 - 01/2003
3	Monoclonal AntibodiesIBA 01/2008 - 02/2004
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2006
2	Hormones (Hormone)IBA 03/2019 - 11/2017
2	CreatinineIBA 01/2018 - 01/2010
2	ClusterinIBA 01/2018 - 06/2014
2	Interleukin-8 (Interleukin 8)IBA 01/2013 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 10/2003
2	Mitogen-Activated Protein KinasesIBA 06/2009 - 02/2004
2	Insulin-Like PeptidesIBA 02/2009 - 09/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2008 - 03/2006
2	Urokinase Plasminogen Activator ReceptorsIBA 03/2006 - 02/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006 - 01/2003
1	Surface-Active Agents (Surfactants)IBA 06/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	CateninsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 02/2021
1	LigandsIBA 01/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Selenoprotein WIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	GalactosidasesIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	Sirtuin 1IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	TetraspaninsIBA 01/2020
1	ZincIBA 10/2019

Therapy/Procedure

10	Therapeutics 01/2016 - 07/2006
3	Cochlear Implants (Cochlear Implant) 01/2017 - 08/2011
3	Cochlear Implantation 04/2016 - 10/2007
1	Electrodes (Electrode) 06/2022